LentiSuite & LentiStarter High-Titer Lentivirus Kits
View ProductsVirus Concentration Kits & Titering
- PEG-it Virus Precipitation Solution
- Retro-Concentin Retroviral Concentration Reagent
- Global UltraRapid Lentiviral Titering Kit
Viral Transduction and Transfection
- TransDux MAX Lentivirus Transduction Reagent
- TransDux (Original) Virus Transduction Reagent
- PureFection Transfection Reagent
Resources
Lentivirus FAQs
Lentiviruses are a type of retrovirus that can be used to deliver cDNA, shRNAs, microRNAs, or transcription reporters to dividing and non-dividing cells. Once introduced into the target cells, the introduced transgene integrates into the host cell genome to provide permanent expression of the transgene.
There is about 20% HIV sequence in SBI's lentivectors. Below are examples of the percentage of the HIV genome found in CD510B-1 (pCDH-CMV-MCS-EF1-Puro) (7377 bps)
| Element | Length (bps) |
|---|---|
| Hybrid RSV/5'LTR | 407 |
| RRE | 232 |
| Env | 488 |
| cPPT | 118 |
| 3' LTR | 233 |
| Total HIV genome | 1478 |
| % HIV in vectors | 1478/7377 x100= 20% |
Most cell-types and tissues tested are capable of successful lentiviral transduction. To view a profile of cell lines evaluated.
The basic requirements are a working laminar flow hood and biosafety level 2 procedures. Follow this link to view the recommendations by the Center for Disease Control (CDC website information)
This depends upon the lentivector you are choosing. The region between the 5’and 3’LTR must not exceed 9kb, which is the size of the native HIV genome. To calculate the size of the insert that the lentivector can accommodate, download the vector sequence and determine the size of this region. The difference between 9kb and the size of the 5’- to 3’-LTR is the limit of the size of the insert. Typically most SBI lentivectors can accommodate a fragment of 4 kb, however the all-in-one SparQ vectors can only accommodate up to 3 kb. The reasons for the limitation are there is only so much room in the virus capsid, integration efficiency also goes down, and transcription slows down because of the large size.
No. For biosafety reasons it is not possible to create a stable cell line to continuously produce lentiviral particles. For a full protocol on how to produce lentiviral particles, please see: Lentiviral Expression Systems user manual.
